The UK Government's research efforts into 'long Covid' may present an opportunity for artificial intelligence (AI) to prove its medical worth, but there will be challenges.
The discussed need for a Covid-19 vaccine booster in response to the existing variants will benefit pharma companies and CMOs.
The US Federal Reserve has committed to actively generate a period of inflation above 2%, while the ECB might passively tolerate a period of inflation above 2%.
Lapses in Covid-19 vaccine procurement by the government has thrown Australia into turmoil with increasing transmission, increased restrictions and a likely second recession.
The use of trusted technologies may help overcome the misinformation barriers that surround mRNA Covid-19 vaccine candidates.